Novel treatment strategy for NRAS-mutated melanoma through a selective inhibitor of CD147/VEGFR-2 interaction

Citation
Landras, A., Reger de Moura, C., Villoutreix, B. O., Battistella, M., Sadoux, A., Dumaz, N., Menashi, S., Fernández-Recio, J., Lebbé, C., & Mourah, S. (2022). Novel treatment strategy for NRAS-mutated melanoma through a selective inhibitor of CD147/VEGFR-2 interaction. Oncogene, 41(15), 2254–2264. https://doi.org/10.1038/s41388-022-02244-7
DOI:
DOI: 10.1038/s41388-022-02244-7
Year of publication:
2022
Authors participating in BCBHub:
Juan Fernández Recio